Cintodac Capsule

Cintodac capsule is a combination of medicine used in the treatment of Gerd, Acidity, And Bloating. The medicine contains two active drug Cinitapride in 3mg which helps improve gastrointestinal motility and Pantoprazole in 40mg, a proton pump inhibitor that reduces stomach acid production.

The combination helps improve symptoms such as heartburn, acid reflux and abdominal discomfort. The medicine exact dosage and duration is recommended by the healthcare professional.

​

• Uesd Gerd, acidity and bloating

Cinitapride 3mg capsule cause certain side effects. However, some patients may experience severe symptoms and some experience mild symptoms. It depends on the patient's body how it responds. Consult the healthcare professional if any of the symptoms persist:

• Headache
• Diarrhea
• Stomach pain
• Flatulence
• Dizziness
• Chest pain
• Constipation
• Itching
• Loose and watery stools
• Gas or fart

• Pantoprazole in 40mg capsule should be taken 30-40 minutes before food as advised by the healthcare professional. Follow the exact recommendation on the dosage and timings to ensure safe and effective treatment option.
• Swallow the whole glass of water without chewing or crushing the capsule. The medication should be taken under doctor strict guidance to avoid side effects and ensure proper management of the condition.​
  

• The lower esophageal sphincter (LES), muscle weakens or relaxes too often, allowing acid to escape and cause GERD and bloating. These three are interconnected digestive issues where stomach acids flows back into the esophagus, leading to burning.
• Cintodac capsule contains proton pump inhibitor (PPi) powerful inhibitor that significantly reduce stomach acid by blocking the final step of acid production.​​
  

• Macharla, S., & Bairam, R. (2018). Analytical method development and validation for simultaneous estimation of cinitapride hydrogen tartrate and pantoprazole sodium in pharmaceutical dosage form by RP-HPLC. Der. Pharma. Chemica, 10, 1123-1128. https://www.derpharmachemica.com/pharma-chemica/analytical-method-development-and-validation-for-simultaneous-estimation-of-cinitapride-hydrogen-tartrate-and-pantoprazole-sodium-15273.html
• Vidyadhara, S., Rao, Y. S., Ramu, A., Sasidhar, R. L., & Ramya, A. J. (2013). Method development and validation for the simultaneous estimation of cinitapride and pantoprazole in solid dosage forms by RP-HPLC. Oriental Journal of Chemistry, 29(3), 1213. https://www.orientjchem.org/vol29no3/method-development-and-validation-for-the-simultaneous-estimation-of-cinitapride-and-pantoprazole-in-solid-dosage-forms-by-rp-hplc/
• Bhuva, S. D., & Patel, M. M. (2012). Spectrophotometric simultaneous estimation of omeprazole and cinitapride in bulk and formulation. Asian Journal of Pharmaceutical and Clinical Research, 5(4), 40-42.
• Shivakrishna, N., Jahnavi, N. S., Marella, P., Krishna, G. P. R., Kumar, V. D. S., & Rao, P. V. Pharmaceutical and Nano Sciences.
• Mathew, M., Madathil, S., Govind, A., & Swamy, V. B. (2016). Formulation and Evaluation of Cinitapride Controlled Release Tablets. Asian Journal of Pharmaceutical Research, 6(2), 87-94.